Research advance of surgical transcatheter mitral valve repair_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

JIANG Chenyu ,  ZHAO Qiang ,  YE Xiaofeng

Department of Cardiac Surgery, Ruijin Hospital, Shanghai Jiaotong University, Shanghai, 20001, P.R.China;

Corresponding author：

ZHAO Qiang, Email: xiaofengye@hotmail.com; YE Xiaofeng, Email: xiaofengye@hotmail.com

Keywords：

Surgery; transcatheter; mitral regurgitation; valve leaflet repair

DOI：

10.7507/1007-4848.201810014

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Mitral regurgitation (MR) with multi-pathogenesis is a common disease in cardiac surgery department. MR can be classified into two categories-primary mitral regurgitation and secondary mitral regurgitation. With the development of cardiac intervention, numerous patients who cannot tolerate open heart surgery for the reason of high risk of surgery receive the treatment of intervention and achieve the favorable endpoint. The technique of transcatheter therapy which could be used to treat MR is comprised of leaflet repair, annuloplasty and implantation of artificial chordae. Comparing to primary mitral regurgitation, surgical effect of secondary mitral regurgitation is not desirable for the reasons of complex pathophysiologic mechanism. Hence, based on the perspective of surgeon, we will introduce the research progress of transcatheter interventional mitral valve repair which is focused on the treatment of primary mitral valve regurgitation and reviewed from three aspects of surgical risks, surgical types and outlook.

Citation： JIANG Chenyu, ZHAO Qiang, YE Xiaofeng. Research advance of surgical transcatheter mitral valve repair. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2019, 26(7): 708-714. doi: 10.7507/1007-4848.201810014 Copy

1.	Ibánez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Revista Española de Cardiología (English Edition), 2017, 70(12): 1082.
2.	Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes. Journal of Nuclear Cardiology, 2017, 24(2): 439-463.
3.	Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur J Cardio-Thorac Surg, 2012, 42(4): S1-S44.
4.	Lim DS, Reynolds MR, Feldman T, et al. Improved unctional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardio, 2014, 64(2): 182-192.
5.	Lapar DJ, Isbell JM, Crosby IK, et al. Multicenter evaluation of high-risk mitral valve operations: implications for novel transcatheter valve therapies. Ann Thorac Surg, 2014, 98(6): 2032-2038.
6.	Paranskaya L, D Ancona G, Bozdag-Turan I, et al. Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata. EuroIntervention, 2012, 8(5): 571-578.
7.	Puls M, Tichelbäcker T, Bleckmann A, et al. Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip. EuroIntervention, 2014, 9(12): 1407-1417.
8.	Velu JF, Kortlandt FA, Hendriks T, et al. Percutaneous mitral valve repair. J Am Coll Cardiol, 2017, 69(23): 2875-2876.
9.	Velu JF, Kortlandt FA, Hendriks T, et al. Comparison of outcome after percutaneous mitral valve repair with the mitraclip in patients with versus without atrial fibrillation. Am J Cardiol, 2017, 120(11): 2035-2040.
10.	Jabs A, von Bardeleben R, Boekstegers P, et al. Effects of atrial fibrillation and heart rate on percutaneous mitral valve repair with MitraClip: results from the TRAnscatheter Mitral valve Interventions (TRAMI) registry. EuroIntervention, 2017, 12(14): 1697-1705.
11.	Saji M, Katz MR, Ailawadi G, et al. Predictive value of age-adjusted charlson co-morbidity index for 1-, 3-, and 5-year mortality in patients requiring transcatheter mitral valve repair. The American Journal of Cardiology, 2017, 120(2): 309-314.
12.	Ledwoch J, Franke J, Lubos E, et al. Prognostic value of preprocedural 6-min walk test in patients undergoing transcatheter mitral valve repair—insights from the German transcatheter mitral valve interventions registry. Clinical Research in Cardiology, 2018, 107(3): 241-248.
13.	Itabashi Y, Utsunomiya H, Kubo S, et al. Different indicators for postprocedural mitral stenosis caused by single- or multiple-clip implantation after percutaneous mitral valve repair. Journal of Cardiology, 2018, 71(4): 336-345.
14.	Sorini Dini C, Landi D, Meucci F, et al. Unexpected delayed complete atrioventricular block after Cardioband implantation. Catheter Cardiovasc Interv, 2018, 92(6): 1201-1204.
15.	Toyama K, Rader F, Kar S, et al. Iatrogenic atrial aeptal sefect after percutaneous mitral valve repair with the mitraClip System. American J Cardio, 2018, 121(4): 475-479.
16.	Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. revista española de cardiología (English edition), 2018, 71(2): 110.
17.	Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
18.	Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary. Circulation, 2014, 129(23): 2440.
19.	St. Goar FG, Fann JI, Komtebedde J, et al Endovascular edge-to-edge mitral valve repair. Circulation, 2003, 108(16): 1990-1993.
20.	Glower DD, Kar S, Trento A, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients. J Am Coll Cardio, 2014, 64(2): 172-181.
21.	Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip Therapy in Europe. J Am Coll Cardio, 2013, 62(12): 1052-1061.
22.	Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair. J Am Coll Cardio, 2012, 59(2): 130-139.
23.	Scandura S, Capranzano P, Caggegi A, et al. Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry. Inter J Cardiol, 2016, 224: 440-446.
24.	Swaans MJ, Bakker ALM, Alipour A, et al. Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. JACC, 2014, 7(8): 875-881.
25.	Doshi R, Shlofmitz E, Shah J, et al. Comparison of transcatheter mitral valve repair versus surgical mitral valve repair in patients with advanced kidney disease (from the national inpatient sample). Am J Cardiol, 2018, 121(6): 762-767.
26.	Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation. J Am Coll Cardio, 2015, 66(25): 2844-2854.
27.	Kortlandt F, Velu J, Schurer R, et al. Survival after mitraClip treatment compared to surgical and conservative treatment for high-surgical-risk patients with mitral regurgitation. Circulation: Cardiovasc Interv, 2018, 11(6): e5985.
28.	Kar S, Feldman T, Qasim A, et al. Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients. Heart, 2018: 2017-312605.
29.	Takagi H, Ando T, Umemoto T. A review of comparative studies of MitraClip versus surgical repair for mitral regurgitation. International Journal of Cardiology, 2017, 228: 289-294.
30.	Kaneko H, Neuss M, Weissenborn J, et al. Impact of residual mitral regurgitation after MitraClip implantation. International Journal of Cardiology, 2017, 227: 813-819.
31.	Rihal CS, Sorajja P, Booker JD, et al. Principles of percutaneous paravalvular leak closure. JACC: Cardiovasc Interv, 2012, 5(2): 121-130.
32.	Taramasso M, Zuber M, Gruner C, et al. First-in-man report of residual " intra-clip” regurgitation between two MitraClips treated by AMPLATZER vascular plug Ⅱ. EuroInterv, 2016, 11(13): 1537-1540.
33.	Kubo S, Cox JM, Mizutani Y, et al. Transcatheter procedure for residual mitral regurgitation after mitraclip implantation using amplatzer duct occluderⅡ. JACC: Cardiovasc Interv, 2016, 9(12): 1280-1288.
34.	Liu X, Shi J, Feng X, et al. Short-term and 1-year outcomes after MitraClip therapy in functional versus degenerative mitral regurgitation patients: a systematic review and meta-analysis. J Thorac Dis, 2018, 10(7): 4156-4168.
35.	Giannini C, D'Ascenzo F, Fiorelli F, et al. A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients. ESC Heart Failure, 2018, 5(6): 1150-1158.
36.	De Rosa R, Silverio A, Baldi C, et al. Transcatheter repair of functional mitral regurgitation in heart failure patients ― A meta-analysis of 23 studies on MitraClip implantation . Circ J, 2018, 82(11): 2800-2810.
37.	Baldino G, Persi F, Mortola P, et al. An alternative technique to achieve haemostasis during PEVAR using perclose proGlide. EJVES Short Reports, 2018, 41: 8-9.
38.	Mack MJ, Abraham WT, Lindenfeld J, et al. Cardiovascular outcomes assessment of the MitraClip in patients with heart Failure and secondary mitral regurgitation: design and rationale of the COAPT trial. Am Heart J, 2018, 205: 1-11.
39.	Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med, 2019, 380(20): 1980-1981.
40.	Mcmurray JJV, Packer M, Desai AS, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. New England Journal of Medicine, 2014, 371(11): 993-1004.
41.	Grasso C, Popolo RA. The PASCAL transcatheter mitral valve repair system for the treatment of mitral regurgitation: another piece to the puzzle of edge-to-edge technique. J Thorac Dis, 2017, 9(12): 4856-4859.
42.	Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet, 2017, 390(10096): 773-780.
43.	Wang S, Meng X, Luo Z, et al. Transapical Beating-Heart Mitral Valve Repair Using a Novel Artificial Chordae Implantation System. Ann Thorac Surg, 2018, 106(5): e265-e267.
44.	Tiroch K, Brinkmann H, Koudonas D, et al. "First-in-man" MitraClip via pulmonary vein access through a right mini-thoracotomy in a patient with agenesis of the inferior vena cava. EuroIntervention, 2015, 10(11): 1204-1207.
45.	Frerker C, Meincke F, Seibert H, et al. MitraClip® via direct right atrial access in case of a missing inferior vena cava. EuroIntervention, 2013, 9(5): 643-647.
46.	Okada A, Kanzaki H, Amaki M, et al. Successful treatment of mitral regurgitation after transapical transcatheter aortic valve implantation by percutaneous edge-to-edge mitral valve repair (MitraClip^®) -The first combination therapy performed in Japan-. Inter Med, 2018, 57(8): 1105-1109.
47.	Nickenig G, Hammerstingl C. The Mitralign transcatheter direct mitral valve annuloplasty system. EuroIntervention, 2015, 14(W): W62-W63.
48.	Nickenig G, Hammerstingl C, Schueler R, et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation. JACC: Cardiovasc Interv, 2016, 9(19): 2039-2047.
49.	Maisano F, Taramasso M, Nickenig G, et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J, 2016, 37(10): 817-825.
50.	Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. European Heart Journal, 2018.
51.	von Bardeleben RS, Colli A, Schulz E, et al. First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and neochord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography fusion imaging. Eur Heart J, 2018, 39(15): 1314-1315.
52.	Latib A, Ancona MB, Ferri L, et al. Percutaneous direct annuloplasty with cardioband to treat recurrent mitral regurgitation after mitraClip implantation. JACC: Cardiovasc Interv, 2016, 9(18): e191-e192.
53.	Stephan Von Bardeleben R, Tamm A, Emrich T, et al. Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband. Eur Heart Journal, 2017, 38(9): 690.
54.	Kwon MH, Lee LS, Cevasco M, et al. Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation. J Thorac Cardiovasc Surg, 2013, 146(3): 616-622.
55.	Shapira Y. The Cardioband annuloplasty system: is it ready for prime time? Eur Heart J, 2019, 40(5): 473-475.
56.	Colli A, Zucchetta F, Torregrossa G, et al. Transapical off-pump mitral valve repair with Neochord Implantation (TOP-MINI): step-by-step guide. Ann Cardiothorac Surg, 2015, 4(3): 295-297.
57.	Rucinskas K, Janusauskas V, Zakarkaite D, et al. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: Early results of a single-center experience. JThorac Cardiovasc Surg, 2014, 147(1): 95-99.
58.	Colli A, Manzan E, Zucchetta F, et al. Transapical off-pump mitral valve repair with Neochord implantation: Early clinical results. Intern JCardiol, 2016, 204: 23-28.
59.	Colli A, Manzan E, Aidietis A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation†. Euro J Cardio-Thorac Surg, 2018, 54(3): 460-466.
60.	Colli A, Besola L, Montagner M, et al. Prognostic impact of leaflet-to-annulus index in patients treated with transapical off-pump echo-guided mitral valve repair with NeoChord implantation. Intern J Cardiol, 2018, 257: 235-237.
61.	Colli A, Besola L, Bizzotto E, et al. Edge-to-edge mitral valve repair with transapical neochord implantation. J Thorac Cardiovasc Surg, 2018, 156(1): 144-148.
62.	Tang GHL, Szeto WY. Transapical simultaneous edge-to-edge neochord repair: A new way to manage bileaflet prolapse? J Thorac Cardiovasc Surg, 2018, 156(1): 149-150.
63.	Gammie JS, Wilson P, Bartus K, et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device. Circulation, 2016, 134(3): 189-197.
64.	Gammie JS, Bartus K, Gackowski A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device. J Am Coll Cardio, 2018, 71(1): 25-36.
65.	Pedersen WR, Block P, Leon M, et al. iCoapsys mitral valve repair system: Percutaneous implantation in an animal model. Catheteriz Cardiovasc Interv, 2008, 72(1): 125-131.

1. Ibánez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Revista Española de Cardiología (English Edition), 2017, 70(12): 1082.
2. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes. Journal of Nuclear Cardiology, 2017, 24(2): 439-463.
3. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur J Cardio-Thorac Surg, 2012, 42(4): S1-S44.
4. Lim DS, Reynolds MR, Feldman T, et al. Improved unctional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardio, 2014, 64(2): 182-192.
5. Lapar DJ, Isbell JM, Crosby IK, et al. Multicenter evaluation of high-risk mitral valve operations: implications for novel transcatheter valve therapies. Ann Thorac Surg, 2014, 98(6): 2032-2038.
6. Paranskaya L, D Ancona G, Bozdag-Turan I, et al. Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata. EuroIntervention, 2012, 8(5): 571-578.
7. Puls M, Tichelbäcker T, Bleckmann A, et al. Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip. EuroIntervention, 2014, 9(12): 1407-1417.
8. Velu JF, Kortlandt FA, Hendriks T, et al. Percutaneous mitral valve repair. J Am Coll Cardiol, 2017, 69(23): 2875-2876.
9. Velu JF, Kortlandt FA, Hendriks T, et al. Comparison of outcome after percutaneous mitral valve repair with the mitraclip in patients with versus without atrial fibrillation. Am J Cardiol, 2017, 120(11): 2035-2040.
10. Jabs A, von Bardeleben R, Boekstegers P, et al. Effects of atrial fibrillation and heart rate on percutaneous mitral valve repair with MitraClip: results from the TRAnscatheter Mitral valve Interventions (TRAMI) registry. EuroIntervention, 2017, 12(14): 1697-1705.
11. Saji M, Katz MR, Ailawadi G, et al. Predictive value of age-adjusted charlson co-morbidity index for 1-, 3-, and 5-year mortality in patients requiring transcatheter mitral valve repair. The American Journal of Cardiology, 2017, 120(2): 309-314.
12. Ledwoch J, Franke J, Lubos E, et al. Prognostic value of preprocedural 6-min walk test in patients undergoing transcatheter mitral valve repair—insights from the German transcatheter mitral valve interventions registry. Clinical Research in Cardiology, 2018, 107(3): 241-248.
13. Itabashi Y, Utsunomiya H, Kubo S, et al. Different indicators for postprocedural mitral stenosis caused by single- or multiple-clip implantation after percutaneous mitral valve repair. Journal of Cardiology, 2018, 71(4): 336-345.
14. Sorini Dini C, Landi D, Meucci F, et al. Unexpected delayed complete atrioventricular block after Cardioband implantation. Catheter Cardiovasc Interv, 2018, 92(6): 1201-1204.
15. Toyama K, Rader F, Kar S, et al. Iatrogenic atrial aeptal sefect after percutaneous mitral valve repair with the mitraClip System. American J Cardio, 2018, 121(4): 475-479.
16. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. revista española de cardiología (English edition), 2018, 71(2): 110.
17. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
18. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary. Circulation, 2014, 129(23): 2440.
19. St. Goar FG, Fann JI, Komtebedde J, et al Endovascular edge-to-edge mitral valve repair. Circulation, 2003, 108(16): 1990-1993.
20. Glower DD, Kar S, Trento A, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients. J Am Coll Cardio, 2014, 64(2): 172-181.
21. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip Therapy in Europe. J Am Coll Cardio, 2013, 62(12): 1052-1061.
22. Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair. J Am Coll Cardio, 2012, 59(2): 130-139.
23. Scandura S, Capranzano P, Caggegi A, et al. Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry. Inter J Cardiol, 2016, 224: 440-446.
24. Swaans MJ, Bakker ALM, Alipour A, et al. Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. JACC, 2014, 7(8): 875-881.
25. Doshi R, Shlofmitz E, Shah J, et al. Comparison of transcatheter mitral valve repair versus surgical mitral valve repair in patients with advanced kidney disease (from the national inpatient sample). Am J Cardiol, 2018, 121(6): 762-767.
26. Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation. J Am Coll Cardio, 2015, 66(25): 2844-2854.
27. Kortlandt F, Velu J, Schurer R, et al. Survival after mitraClip treatment compared to surgical and conservative treatment for high-surgical-risk patients with mitral regurgitation. Circulation: Cardiovasc Interv, 2018, 11(6): e5985.
28. Kar S, Feldman T, Qasim A, et al. Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients. Heart, 2018: 2017-312605.
29. Takagi H, Ando T, Umemoto T. A review of comparative studies of MitraClip versus surgical repair for mitral regurgitation. International Journal of Cardiology, 2017, 228: 289-294.
30. Kaneko H, Neuss M, Weissenborn J, et al. Impact of residual mitral regurgitation after MitraClip implantation. International Journal of Cardiology, 2017, 227: 813-819.
31. Rihal CS, Sorajja P, Booker JD, et al. Principles of percutaneous paravalvular leak closure. JACC: Cardiovasc Interv, 2012, 5(2): 121-130.
32. Taramasso M, Zuber M, Gruner C, et al. First-in-man report of residual " intra-clip” regurgitation between two MitraClips treated by AMPLATZER vascular plug Ⅱ. EuroInterv, 2016, 11(13): 1537-1540.
33. Kubo S, Cox JM, Mizutani Y, et al. Transcatheter procedure for residual mitral regurgitation after mitraclip implantation using amplatzer duct occluderⅡ. JACC: Cardiovasc Interv, 2016, 9(12): 1280-1288.
34. Liu X, Shi J, Feng X, et al. Short-term and 1-year outcomes after MitraClip therapy in functional versus degenerative mitral regurgitation patients: a systematic review and meta-analysis. J Thorac Dis, 2018, 10(7): 4156-4168.
35. Giannini C, D'Ascenzo F, Fiorelli F, et al. A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients. ESC Heart Failure, 2018, 5(6): 1150-1158.
36. De Rosa R, Silverio A, Baldi C, et al. Transcatheter repair of functional mitral regurgitation in heart failure patients ― A meta-analysis of 23 studies on MitraClip implantation . Circ J, 2018, 82(11): 2800-2810.
37. Baldino G, Persi F, Mortola P, et al. An alternative technique to achieve haemostasis during PEVAR using perclose proGlide. EJVES Short Reports, 2018, 41: 8-9.
38. Mack MJ, Abraham WT, Lindenfeld J, et al. Cardiovascular outcomes assessment of the MitraClip in patients with heart Failure and secondary mitral regurgitation: design and rationale of the COAPT trial. Am Heart J, 2018, 205: 1-11.
39. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med, 2019, 380(20): 1980-1981.
40. Mcmurray JJV, Packer M, Desai AS, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. New England Journal of Medicine, 2014, 371(11): 993-1004.
41. Grasso C, Popolo RA. The PASCAL transcatheter mitral valve repair system for the treatment of mitral regurgitation: another piece to the puzzle of edge-to-edge technique. J Thorac Dis, 2017, 9(12): 4856-4859.
42. Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet, 2017, 390(10096): 773-780.
43. Wang S, Meng X, Luo Z, et al. Transapical Beating-Heart Mitral Valve Repair Using a Novel Artificial Chordae Implantation System. Ann Thorac Surg, 2018, 106(5): e265-e267.
44. Tiroch K, Brinkmann H, Koudonas D, et al. "First-in-man" MitraClip via pulmonary vein access through a right mini-thoracotomy in a patient with agenesis of the inferior vena cava. EuroIntervention, 2015, 10(11): 1204-1207.
45. Frerker C, Meincke F, Seibert H, et al. MitraClip® via direct right atrial access in case of a missing inferior vena cava. EuroIntervention, 2013, 9(5): 643-647.
46. Okada A, Kanzaki H, Amaki M, et al. Successful treatment of mitral regurgitation after transapical transcatheter aortic valve implantation by percutaneous edge-to-edge mitral valve repair (MitraClip^®) -The first combination therapy performed in Japan-. Inter Med, 2018, 57(8): 1105-1109.
47. Nickenig G, Hammerstingl C. The Mitralign transcatheter direct mitral valve annuloplasty system. EuroIntervention, 2015, 14(W): W62-W63.
48. Nickenig G, Hammerstingl C, Schueler R, et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation. JACC: Cardiovasc Interv, 2016, 9(19): 2039-2047.
49. Maisano F, Taramasso M, Nickenig G, et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J, 2016, 37(10): 817-825.
50. Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. European Heart Journal, 2018.
51. von Bardeleben RS, Colli A, Schulz E, et al. First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and neochord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography fusion imaging. Eur Heart J, 2018, 39(15): 1314-1315.
52. Latib A, Ancona MB, Ferri L, et al. Percutaneous direct annuloplasty with cardioband to treat recurrent mitral regurgitation after mitraClip implantation. JACC: Cardiovasc Interv, 2016, 9(18): e191-e192.
53. Stephan Von Bardeleben R, Tamm A, Emrich T, et al. Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband. Eur Heart Journal, 2017, 38(9): 690.
54. Kwon MH, Lee LS, Cevasco M, et al. Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation. J Thorac Cardiovasc Surg, 2013, 146(3): 616-622.
55. Shapira Y. The Cardioband annuloplasty system: is it ready for prime time? Eur Heart J, 2019, 40(5): 473-475.
56. Colli A, Zucchetta F, Torregrossa G, et al. Transapical off-pump mitral valve repair with Neochord Implantation (TOP-MINI): step-by-step guide. Ann Cardiothorac Surg, 2015, 4(3): 295-297.
57. Rucinskas K, Janusauskas V, Zakarkaite D, et al. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: Early results of a single-center experience. JThorac Cardiovasc Surg, 2014, 147(1): 95-99.
58. Colli A, Manzan E, Zucchetta F, et al. Transapical off-pump mitral valve repair with Neochord implantation: Early clinical results. Intern JCardiol, 2016, 204: 23-28.
59. Colli A, Manzan E, Aidietis A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation†. Euro J Cardio-Thorac Surg, 2018, 54(3): 460-466.
60. Colli A, Besola L, Montagner M, et al. Prognostic impact of leaflet-to-annulus index in patients treated with transapical off-pump echo-guided mitral valve repair with NeoChord implantation. Intern J Cardiol, 2018, 257: 235-237.
61. Colli A, Besola L, Bizzotto E, et al. Edge-to-edge mitral valve repair with transapical neochord implantation. J Thorac Cardiovasc Surg, 2018, 156(1): 144-148.
62. Tang GHL, Szeto WY. Transapical simultaneous edge-to-edge neochord repair: A new way to manage bileaflet prolapse? J Thorac Cardiovasc Surg, 2018, 156(1): 149-150.
63. Gammie JS, Wilson P, Bartus K, et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device. Circulation, 2016, 134(3): 189-197.
64. Gammie JS, Bartus K, Gackowski A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device. J Am Coll Cardio, 2018, 71(1): 25-36.
65. Pedersen WR, Block P, Leon M, et al. iCoapsys mitral valve repair system: Percutaneous implantation in an animal model. Catheteriz Cardiovasc Interv, 2008, 72(1): 125-131.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Research advance of surgical transcatheter mitral valve repair

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content